FBN33428, also referred to as Fmoc-Phe-Lys(Boc)-PAB, is a hydrolyzable linker utilized in the synthesis of antibody-drug conjugates (ADCs). This compound facilitates the creation of hydrolyzable prodrugs, enhancing the targeted delivery of anticancer drugs to metastatic cells.